title: Validating the benefits of lipid modifying therapies upon atherosclerotic plaque by computed tomography angiography: should we trust our eyes? Commentary on the study of Zeb et al.
authors.affiliation: Heart Institute (InCor)- University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil.
authors.forename: Fabiana H
authors.initials: FH
authors.lastname: Rached
authors.forename: Raul D
authors.initials: RD
authors.lastname: Santos
mesh_terms: D003324:Coronary Artery Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D058226:Plaque, Atherosclerotic / Q000188:drug therapy*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
keywords: Atherosclerosis; Computed tomography angiography; Inflammation; LDL-cholesterol; Plaque burden; Statins